InsidersTradesSigma
Enorama Pharma AB: directors' dealings · Finland · FIN-FSA
FI:enorama-pharma-abSE0021629151FI·FIN-FSAMcap 21M€Healthcare
Explore the full management transaction log of Enorama Pharma AB, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Enorama Pharma AB has published 1 reports. Market capitalisation: €21.2m. The latest transaction was reported on 9 September 2025 — Purchase. Among the most active insiders: Bengt Jönsson. The full history is openly available.
1
Insider Decl.
0
Thresholds
€795,981
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.28 €
Analyst consensus
Income statement
Revenue2.7 M€
Gross profit−15.0 M€-549% margin
Net income−75.1 M€-2743.3% margin
Valuation
Beta1.60
Balance sheet & cash
Market cap21.2 M€
Free Cash Flow−59.3 M€
Profitability & ownership
ROA-321.4%
% insiders93.6%
% institutions0.0%
Last declaration on 9 September 2025
Declarations1 total
Executives●Purchase31FIN-FSA
€795,9813,811,481 shares@ €0.20883.76% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003S139-1·
Ideal exit: 5 Jun 2026 (T+270)
1 of 1 declaration